Halda Therapeutics last raised $126.5M in its Later Stage VC (Series B) (Jul 2024).
- ·The complete investor list: 14 names
- ·Watch Halda Therapeutics: the Monday email on marks, rounds and moves
Halda Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Later Stage VC (Series B) | $126.5M | ▮ | ▮ |
| Dec 2021 | Early Stage VC | $41.0M | ▮ | ▮ |
| Feb 2019 | Early Stage VC | $6.3M | ▮ | ▮ |
Membership and data by Private Market View
Halda Therapeutics valuation
Halda Therapeutics's last known valuation is $3 billion. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Halda Therapeutics raised?
Halda Therapeutics has raised $227 million across 3 recorded rounds since 2019. The largest was a $6.3 million early-stage round in Feb 2019; the most recent was a $126 million Series B in Jul 2024.
Halda Therapeutics has filed 4 Form Ds with the SEC since 2019, most recently in Aug 2024 ($126 million sold to 20 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Tubulis ($5.8 billion), Encoded Therapeutics ($1.8 billion) and Formation Bio ($1.7 billion).
How Halda Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Halda Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Halda Therapeutics
- What is Halda Therapeutics worth?
- Halda Therapeutics's last known valuation is $3.0B.
- How much has Halda Therapeutics raised?
- Halda Therapeutics has raised $227.1M in total funding across 3 recorded rounds.
- When did Halda Therapeutics last raise?
- Halda Therapeutics last raised in Jul 2024 (Later Stage VC (Series B)), raising $126.5M.